Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 8/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 3/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.38 |
| ▸ | SELP | P16109 | 1/20 | 0.38 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.38 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22693786 | 0.86 | ALDH1A1 (0.46) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL3832638 | 0.84 | ALDH1A1 (0.45) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL1982495 | 0.83 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2AFAAHCNR1 | |
| SCHEMBL7616135 | 0.81 | GPR84 (0.42) | ALDH1A1MEN1KMT2AFAAHNAAA | |
| SCHEMBL3831548 | 0.75 | ALDH1A1 (0.48) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL22693798 | 0.74 | ALDH1A1 (0.45) | ALDH1A1MEN1KMT2AUSP2MAPT | |
| SCHEMBL2796329 | 0.74 | GPR84 (0.59) | FAAHNAAA | |
| SCHEMBL8036434 | 0.74 | CTSD (0.48) | FAAH | |
| SCHEMBL13475438 | 0.74 | MCL1 (0.45) | ALDH1A1MEN1KMT2AUSP2NAAA | |
| SCHEMBL17467157 | 0.74 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2AUSP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120328536-A1 | Taste Improving Substances | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2012-12-27 | — | — | US | claimed |
| EP-1854782-B1 | Taste improving composition | GIVAUDAN NEDERLAND SERVICES B (NL) | 2009-09-30 | — | — | EP | claimed |
| EP-1854782-A1 | Taste improving composition | Quest International Services B.V. (NL) | 2007-11-14 | — | — | EP | claimed |
| US-20070259089-A1 | Taste improving substances | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2007-11-08 | — | — | US | claimed |
| US-8691311-B2 | Taste improving substances | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2014-04-08 | — | — | US | disclosed |
| US-20120328536-A1 | Taste Improving Substances | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2012-12-27 | — | — | US | disclosed |
| US-20120328536-A1 | Taste Improving Substances | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2012-12-27 | — | — | US | disclosed |
| US-8263161-B2 | Taste improving substances | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2012-09-11 | — | — | US | disclosed |
| US-8263161-B2 | Taste improving substances | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2012-09-11 | — | — | US | disclosed |
| EP-1854782-B1 | Taste improving composition | GIVAUDAN NEDERLAND SERVICES B (NL) | 2009-09-30 | — | — | EP | disclosed |
| EP-1854782-A1 | Taste improving composition | Quest International Services B.V. (NL) | 2007-11-14 | — | — | EP | disclosed |
| EP-1854782-A1 | Taste improving composition | Quest International Services B.V. (NL) | 2007-11-14 | — | — | EP | disclosed |
| US-20070259089-A1 | Taste improving substances | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2007-11-08 | — | — | US | disclosed |
| US-20070259089-A1 | Taste improving substances | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120328536-A1 | Taste Improving Substances | TAS2R5, TAS2R3, TAS2R42 | ALDH1A1 568/4885MEN1 3716/4885KMT2A 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.